Advanced company searchLink opens in new window

BIOCENTIS LIMITED

Company number 12888938

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
10 Jan 2025 AP01 Appointment of Mr Pietro Pascale as a director on 9 January 2025
20 Nov 2024 TM01 Termination of appointment of Tommaso Ulderico Giuseppe Landi as a director on 19 November 2024
19 Sep 2024 CS01 Confirmation statement made on 17 September 2024 with no updates
26 Jun 2024 AA Total exemption full accounts made up to 31 December 2023
23 Oct 2023 AP01 Appointment of Mr Tommaso Ulderico Giuseppe Landi as a director on 18 October 2023
29 Sep 2023 CS01 Confirmation statement made on 17 September 2023 with updates
13 Mar 2023 AA Total exemption full accounts made up to 31 December 2022
12 Jan 2023 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
27 Sep 2022 CS01 Confirmation statement made on 17 September 2022 with updates
27 Sep 2022 SH01 Statement of capital following an allotment of shares on 2 September 2022
  • GBP 29.4356
22 Feb 2022 TM01 Termination of appointment of Matteo Trentini as a director on 21 February 2022
22 Feb 2022 TM01 Termination of appointment of Andrea Crisanti as a director on 21 February 2022
21 Feb 2022 AA Total exemption full accounts made up to 31 December 2021
09 Feb 2022 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of Memorandum and/or Articles of Association
09 Feb 2022 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Subdivision of shares 13/11/2021
09 Feb 2022 MA Memorandum and Articles of Association
01 Feb 2022 PSC07 Cessation of Systemgenomics Ltd as a person with significant control on 27 January 2022
01 Feb 2022 SH01 Statement of capital following an allotment of shares on 27 January 2022
  • GBP 29.1674
28 Jan 2022 AP01 Appointment of Teodoro D'ambrosio as a director on 13 January 2022
28 Jan 2022 AP01 Appointment of Matteo Trentini as a director on 13 January 2022
28 Jan 2022 AP01 Appointment of Andrea Crisanti as a director on 13 January 2022
13 Dec 2021 SH01 Statement of capital following an allotment of shares on 23 November 2021
  • GBP 15.0987
06 Dec 2021 SH02 Sub-division of shares on 4 November 2021
18 Nov 2021 AD01 Registered office address changed from 13 Hanover Square Hanover Square London W1S 1HN England to 22 Glassworks Studios Basing Place London E2 8AB on 18 November 2021
27 Sep 2021 CS01 Confirmation statement made on 17 September 2021 with updates